Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Int Forum Allergy Rhinol. 2022 Jul;12(7):958-962. doi: 10.1002/alr.22944. Epub 2022 Jan 23.
No abstract available

Keywords: medical therapy of chronic rhinosinusitis; olfaction; quality of life.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Chronic Disease
  • Humans
  • Nasal Polyps* / drug therapy
  • Quality of Life
  • Rhinitis* / drug therapy
  • Sinusitis* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab

Associated data

  • ClinicalTrials.gov/NCT02898454
  • ClinicalTrials.gov/NCT02912468